Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

TURBOVAP LV EVAPORATION SYSTEM (2EA)

Closed
FDA-HFP-2026-134777Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract seeks the procurement of two TurboVAP LV Evaporation Systems designed for high-throughput, reproducible, and efficient removal of organic solvents from extracted samples during laboratory sample preparation. These systems are critical for concentrating analytes prior to instrumental analysis, enhancing overall laboratory efficiency by minimizing manual handling time and ensuring consistent sample concentration across batches. The equipment must deliver reliable performance under routine operational conditions to support analytical workflows with precision and throughput. The solicitation, identified as FDA-HFP-2026-134777, was posted on July 31, 2026, with responses due by August 10, 2026. It is classified as a combined solicitation with no set-aside program applied, and falls under NAICS code 334516 for laboratory analytical instrument manufacturing. The contracting office is the FDA Office of Acq Grant Svcs under the Department of Health and Human Services, headquartered in Rockville, Maryland. The place of performance is listed as a location in Colorado, and the primary point of contact is Rodney D. Aytch, reachable via phone or email for inquiries related to the procurement.

General Info

Procure two TurboVAP LV Evaporation Systems for high-throughput sample concentration, FDA-HFP-2026-134777, due August 10, 2026.

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

18888, CO, USA

Set-Aside

NONE

Documents

1

RFQ HFP-2026-134777 TurboVap LV Evaporation System

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Office AddressRockville, MD, 20852, USA

Full Description

Show more

The purpose of this procurement is to acquire two (2) solvent evaporation systems capable of high-throughput, reproducible, and efficient solvent evaporation during sample preparation. The systems shall be used to remove organic solvents from extracted samples, leaving concentrated residues for further analytical processing. The equipment shall improve laboratory efficiency, reduce analyst handling time, and ensure consistent analyte concentration prior to instrumental analysis.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
Solicitation # 75F40126R00009
Solicitation 75F40126R00009 is a request for proposals for a single Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide Contractor-Hosted Fully Integrated Records Facility (FIRF) services for the FDA. This acquisition is exclusively set aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns under NAICS code 541611. The contract has a maximum ceiling of 50 million dollars with a guaranteed minimum of 10,000 dollars. The anticipated period of performance consists of five 12-month ordering periods from December 1, 2026, through November 30, 2031, with an additional six-month option to extend services through May 31, 2032. The contract will support various task order types, including Time-and-Materials, Labor-Hour, and Firm-Fixed Price. The scope of work requires the contractor to manage an offsite document control facility to standardize records management and transition the agency toward a near 100 percent electronic environment for premarket and postmarket submissions. Key task areas include program management, document processing, scanning, data entry, tracking, temporary storage, and transition activities. Performance will primarily occur at FDA facilities in the Washington, D.C. metropolitan area, specifically within Maryland. Award will be made on a Lowest Price-Technically Acceptable (LPTA) basis, evaluating technical factors and past performance on an acceptable or unacceptable basis. Proposals must be submitted electronically in three separate volumes, with a final submission deadline of November 5, 2026, at 2:00 PM Eastern Time.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in 8 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS